KANEKA Your partner in the world of Chirality!
*
> * % '·** ..«ft*
^
And Their
Derivatives
K A N E K A , a technologically versatile company, leading the global chiral marketplace. Providing customers w i t h solid foundations t o s u p p o r t new p r o d u c t development f r o m l a b o r a t o r y and p i l o t plant t o full commercialization through process i n n o v a t i o n . Technologies • Biotransformations, Biotechnologies • Organic chemistry Manufacturing Fro/71 kg to 1,000's MT • Plants for bioprocesses and chemical reactions • Multi-purpose plants and dedicated plants #
• Penems & Carbapenems ACE Inhibitor Intermediates • HMG Co. A Reductase Inhibitor Intermediates · Anti-AIDS Drugs Intermediates • D-Amino acids · Chiral Synthons Kaneka Corporation Fine Chemicals Division 3-2-4, Nakanoshima Kita-Ku Osaka 530-8288, japan Tei: 06-226-5142 Fax: 06-226-5128
[email protected] www.kaneka.co.jp/finechem/ © Kaneka Corporation
Kaneka America Corporation Pharmaceuticals Division 65 East 55th Street New York, N.Y 10022 Tel: 212-705-4340 Fax: 212-705-4350
[email protected] Kaneka Pharma Europe N.V Triomflaan 173 1160 Brussel, Belgium Tel: 02-663-0340 Fax: 02-663-0361
[email protected] CIRCLE 3 0 ON READER SERVICE CARD
Quality Assurance • GMP • M a n y D M F s filed • Producing pharmaceutical bulk & intermediates
nanena